Company Active LTD

Company profile

Sepsis Enterprises Limited

The UK Sepsis Trust Home Page | What is Sepsis? | Sepsis Symptoms

Sepsis Enterprises Limited is a UK company with status active founded in 2015 based in West Midlands.

CRN

09583335

Founded

2015

Age

Overview

Legal name

SEPSIS ENTERPRISES LIMITED

Region

West Midlands

Registered address

AZZURRI HOUSE WALSALL BUSINESS PARK

ALDRIDGE

WALSALL

WEST MIDLANDS

ENGLAND

WS9 0RB

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller

Company Active LTD

Sepsis Enterprises Limited

CRN 09583335

Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC

United Kingdom Sepsis Trust Limited

CRN 08644039

Company events

Reference milestones and recent Companies House filing stream events.

6 events

11 Jun

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec

2026

Accounts due

Accounts Due

Next accounts due date

28 May

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar

2025

Accounts filed

Accounts

Last accounts made up date

26 Nov

2024

Accounts With Accounts Type Small

Accounts PDF pending

AA | Transaction MzQ0NDkwMTI0N2FkaXF6a2N4 | Paper/PDF filed

Published 26 Nov 2024 01:44

11 May

2015

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2023

Funded years

2023

Age at first award

7 years

Projects

2023 Collaborative R&D

Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsis

1 Jan 2023 to 30 Sep 2024

Awarded

£35,110

Total cost £35,110

Neutropenic sepsis (NS) is a life-threatening complication of cancer chemotherapy. It occurs because chemotherapy temporarily suppresses the immune system, particularly neutrophil cells, and even mild illnesses can be fatal for patients during this time. As a result, if any chemotherapy patient has a fever or feels unwell they are advised to attend hospit...

Product types

Collaborative R&D